Medical Condition News

RSS

Research: Intervention by nurses increases likelihood of patient giving up smoking by 28%

Research from the World Health Organisation suggests that intervention by nurses increases the likelihood of a patient giving up smoking by 28%

1 Jun 2013

Five studies on breast, colon and colorectal cancer to be presented at ASCO Annual Meeting

Agendia, a world leader in molecular cancer diagnostics, today announced that results from five studies focused on breast, colon and colorectal cancer will be presented at the upcoming American Society of Clinical Oncology Annual Meeting to be held May 31-June 4, 2013 at McCormick Place in Chicago.

1 Jun 2013

Gulf Coast Spine Care offers effective treatment options for sciatica

Finding relief from sciatica is imperative, and Gulf Coast Spine Care offers proven, effective treatment options for these individuals. Recently, the medical center has started offering additional treatment options for the benefit of its patients who suffer from this condition, and these treatments have provided patients with considerable improvement to their quality of life.

1 Jun 2013

MannKind completes AFREZZA Phase 3 clinical study in patients with type 1 diabetes

MannKind Corporation today announced that all follow-up visits have been completed for the patients enrolled in Study 171, a Phase 3 clinical study of AFREZZA (insulin human [rDNA origin]) inhalation powder, an investigational, ultra rapid-acting mealtime insulin therapy, administered using MannKind's next-generation inhaler. MannKind expects to release data from this study later this summer.

1 Jun 2013

New nanoparticle gene delivery method to prevent stenting procedure complications

Stent angioplasty saves lives, but there often are side effects and complications related to the procedure, such as arterial restenosis and thrombosis. In the June 2013 issue of The FASEB Journal, however, scientists report that they have discovered a new nanoparticle gene delivery method that may overcome current limitations of gene therapy vectors and prevent complications associated with the stenting procedure.

1 Jun 2013

Only one-fifth of RA patients had overall adherence rate to prescribed oral medications, study finds

A new study conducted in an ethnically diverse and predominantly low income population found that only one-fifth of rheumatoid arthritis patients had an overall adherence rate to prescribed oral medications at 80% or greater.

1 Jun 2013

Researchers uncover role of key protein linked to development of cancers

Virginia Commonwealth University researchers studying a key molecular player called Hsp70 that is responsible for protein homeostasis have uncovered how it binds together with another molecule responsible for intracellular energy transfer to enhance its overall activity and efficiency - details that have previously not been well understood.

1 Jun 2013

New research shows uremic toxins increase heart attack risk

MD-Patients with advanced kidney disease who are undergoing hemodialysis are known to be highly susceptible to heart attacks and other cardiovascular complications, and now scientists likely know why.

31 May 2013

Study: Young women with breast cancer often choose mastectomy over surgical procedure

A new study of young women with breast cancer has found that most chose to have a mastectomy rather than a surgical procedure that would conserve the breast, researchers will report at the 49th Annual Meeting of the American Society of Clinical Oncology, May 31-June 4, in Chicago.

31 May 2013

New avatar system could provide quick and effective therapy for schizophrenia

An avatar system that enables people with schizophrenia to control the voice of their hallucinations is being developed by researchers at UCL with support from the Wellcome Trust.

31 May 2013

GLYX-13 drug induces antidepressant results without street drug side effects

GLYX-13, a molecular cousin to ketamine, induces similar antidepressant results without the street drug side effects, reported a study funded by the National Institute of Mental Health (NIMH) that was published last month in Neuropsychopharmacology.

31 May 2013

Soccer training improves heart function, reduces blood pressure in patients with type 2 diabetes

A new study from the Copenhagen Centre for Team Sport and Health at the University of Copenhagen, Denmark, demonstrates that soccer training improves heart function, reduces blood pressure and elevates exercise capacity in patients with type 2 diabetes. Soccer training also reduces the need for medication.

31 May 2013

Omeros announces positive results from OMS824 Phase 1 clinical program

Omeros Corporation today announced positive results from its Phase 1 clinical program evaluating OMS824, the lead compound from its phosphodiesterase 10 (PDE10) program.

31 May 2013

Vanda Pharmaceuticals announces submission of tasimelteon NDA to FDA

Vanda Pharmaceuticals Inc. today announced the submission of a New Drug Application to the U.S. Food and Drug Administration for tasimelteon, a circadian regulator.

31 May 2013

First Edition: May 31, 2013

Today's early morning highlights from the major news organizations, including reports from the administration about the number of insurers that will be offering policies on the new online marketplaces.

31 May 2013

Ragweed allergy sublingual immunotherapy: an interview with Dr. Peter Creticos, Johns Hopkins University School of Medicine

Ragweed is a dominant seasonal allergen in North America (~26% of US and North American population is allergic to this noxious weed which pollinates from early August to early October).

31 May 2013

University of Huddersfield professors publish latest edition of Practical Psychiatry of Old Age

Professor John Wattis and Professor Steven Curran, of the University of Huddersfield, have published the latest edition of this key text on psychiatric conditions in old age.

31 May 2013

Exelixis starts phase 3 pivotal trial of cabozantinib for treatment of metastatic renal cell carcinoma

Exelixis, Inc. today announced it has initiated METEOR, a phase 3 pivotal trial comparing cabozantinib to everolimus in patients with metastatic renal cell carcinoma who have experienced disease progression following treatment with at least one prior VEGFR tyrosine kinase inhibitor.

31 May 2013

Women leaders open conference, urge 'strong bones for strong women' to reduce osteoporosis

More than 140 delegates from 45 countries have joined the International Osteoporosis Foundation and the Finnish Osteoporosis Association for the 14th IOF Worldwide Conference of Osteoporosis Patient Societies.

31 May 2013

Discovery opens doors to new therapies for sepsis

Despite numerous advances in treating infections and disease, effective treatments for sepsis remain elusive. A new discovery published in the June 2013 issue of The FASEB Journal not only could help health care providers predict who is more and less likely to develop sepsis, but it also opens the doors to new therapies that actually address the root cause of the problem, rather than just managing the symptoms.

31 May 2013

Medical Condition News

Research: Intervention by nurses increases likelihood of patient giving up smoking by 28%

Five studies on breast, colon and colorectal cancer to be presented at ASCO Annual Meeting

Gulf Coast Spine Care offers effective treatment options for sciatica

MannKind completes AFREZZA Phase 3 clinical study in patients with type 1 diabetes

New nanoparticle gene delivery method to prevent stenting procedure complications

Only one-fifth of RA patients had overall adherence rate to prescribed oral medications, study finds

Researchers uncover role of key protein linked to development of cancers

New research shows uremic toxins increase heart attack risk

Study: Young women with breast cancer often choose mastectomy over surgical procedure

New avatar system could provide quick and effective therapy for schizophrenia

GLYX-13 drug induces antidepressant results without street drug side effects

Soccer training improves heart function, reduces blood pressure in patients with type 2 diabetes

Omeros announces positive results from OMS824 Phase 1 clinical program

Vanda Pharmaceuticals announces submission of tasimelteon NDA to FDA

First Edition: May 31, 2013

Ragweed allergy sublingual immunotherapy: an interview with Dr. Peter Creticos, Johns Hopkins University School of Medicine

University of Huddersfield professors publish latest edition of Practical Psychiatry of Old Age

Exelixis starts phase 3 pivotal trial of cabozantinib for treatment of metastatic renal cell carcinoma

Women leaders open conference, urge 'strong bones for strong women' to reduce osteoporosis

Discovery opens doors to new therapies for sepsis

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Latest News